Thousands of Canadian breast cancer patients could avoid chemo, according to study

Results are expected to spare patients from having to undergo rounds of chemotherapy

Lisa Freedman, who is now cancer-free, poses for a photo outside her Toronto home on Friday, June 8, 2018. (Tijana Martin/The Canadian Press)

When Lisa Freedman was diagnosed with breast cancer, a genetic test of her tumour suggested chemotherapy would have no effect on the risk of recurrence, allowing her to safely skip the treatment and its dreaded side-effects.

“When the test came back, it showed that I would have a 13-per-cent chance of recurrence if I had chemo and a 12-per-cent chance if I didn’t have chemo,” said the Toronto lawyer, 61.

“So that became an easy no-chemo decision,” said Freedman, who has been cancer-free for two years.

A recently published U.S.-led study of more than 10,000 women whose tumours were tested determined that most patients with early-stage estrogen-positive breast cancer and no lymph-node spread should be able to avoid chemo and be treated with surgery, radiation and a hormone-blocking drug like tamoxifen alone.

The study is the largest ever performed looking at breast cancer treatment, and its results are expected to spare thousands of women in Canada each year from having to undergo rounds of chemotherapy and its harsh side-effects.

Funded by the U.S. National Cancer Institute, with additional funding from the Canadian Cancer Society Research Institute, the research looked at women with breast cancer with an intermediate risk of recurrence, based on their scores from the genetic test.

READ MORE: Centre gives breast cancer patients new outlook on life

Previously, scores from the US$3,000 Oncotype DX test, used since 2004, allowed doctors to sort out women at high risk and low risk of recurrence to determine whether they would benefit from chemotherapy.

But women with in-between scores fell into a grey area — should they get chemo or not?

That’s what the study, which began in 2006 and included 10,253 women aged 18 to 75, set out to determine, with participants randomized to receive chemo plus a hormone-dampening drug or that medication alone.

The results were stunning.

After nine years, the findings put the women virtually in a dead heat: more than 90 per cent of those in both groups were still alive, while almost 85 per cent in each were free of recurrence.

Researchers concluded that almost 70 per cent of women with this form of breast cancer could safely dodge chemotherapy.

“(For) women in-between, where there was some uncertainty, I think this study is very reassuring that for the majority of them we don’t have to give chemotherapy,” said Dr. Andrea Eisen, an oncologist at Sunnybrook Health Sciences Centre in Toronto, where 56 patients took part in the multi-centre trial.

The results represent an evolution in how this most common form of breast cancer will be treated in the future, agreed Dr. David Cescon, a breast medical oncologist and researcher at the Princess Margaret Cancer Centre.

“There have been other studies that have contributed, other supportive information along these lines, which have allowed us to avoid chemotherapy, particularly for women in the lower end of this middle-risk group,” he said.

“But this will allow us to make those recommendations with more confidence, particularly in the higher end of the middle range for older women.”

For Freedman, being told she didn’t need chemo was welcome news, though she admitted that the time from diagnosis to having a surgical lumpectomy and the tumour test moved so quickly, she ”never had to go through that whole angst.”

Still, she was well aware of the horrors of chemo and had wondered how she would be able to work through the treatment regimen.

“I kind of visualized myself lying on the floor in the bathroom throwing up, with my hair falling out and trying to get my strength back,” Freedman said.

“So when (the oncologist) said there was absolutely no need for chemo, it was a sigh of relief, almost tears of relief.”

Eisen said there has been an ongoing shift over the decades in how breast cancer is treated.

“Everybody used to have a mastectomy, then we realized doing a lumpectomy and radiation was essentially just as good,” she said.

“And then everybody used to have an ancillary lymph-node dissection, so removal of a lot of lymph nodes under the arm. And then we realized that a smaller operation called a sentinel node biopsy could give in most cases equivalent information.

“So now this is the first time we’re really looking at drug treatment … That’s kind of a signal of how good the outcomes are becoming, that we’d look at taking away treatment, rather than giving more.”

Sheryl Ubelacker, The Canadian Press

Just Posted

Yellow Vests protestors take to Red Deer streets

Trudeau government’s immigration and oil industry policies denounced at rally

Rebels lose to Medicine Hat Tigers, 4-1

Tigers break Rebels’ three-game winning streak

Red Deer’s newest outdoor ice facility opens to the public next week

The speed skating oval at Setters Place at Great Chief Park will be open Dec. 17th

Exhibition explores the rich history and culture of Métis people

The exhibition is on display from Dec. 15th to March 10th at the Red Deer Museum + Art Gallery

2019 Hockey Alberta Provincial Championship host sites announced

A total of 39 Provincial Championships will be hosted across the province

Trudeau to make it harder for future PM to reverse Senate reforms

Of the 105 current senators, 54 are now independents who have banded together in Independent Senators’ Group

Light at the end of the tunnel for UN climate talks

Meeting in Katowice was meant to finalize how countries report their emissions of greenhouses gases

Supreme Court affirms privacy rights for Canadians who share a computer

Section 8 of the Charter of Rights and Freedoms protects Canadians against unreasonable search and seizure

Janet Jackson, Def Leppard, Nicks join Rock Hall of Fame

Radiohead, the Cure, Roxy Music and the Zombies will also be ushered in at the 34th induction ceremony

‘I practically begged’: B.C. woman with breast cancer denied referral to Calgary

Breast cancer patient left to fight disease alone after being denied referral to Calgary

Facebook reveals bug gave apps unauthorized access to 6.8 million users’ photos

It’s believed up to 1,500 apps built by 876 developers had access to Facebook Stories, private photos

21 detained before Paris protests as police deploy in force

There was a strong police presence outside the central Saint Lazare train station, where police in riot gear checked bags

New home for Calgary Flames estimated to cost up to $600 million

The city and the Flames are not yet talking on who will pay how much for a building to replace the Saddledome

Family searching for B.C. professor last seen at Colombian salsa club

Ramazan Gencay, a professor in economics at Simon Fraser University, was last seen in Medellin

Most Read